Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity

Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity

Summary Objective There is an unmet medical need for a safe and effective weight loss product with minimal systemic side‐effects. In this study, the effect of a novel modified‐release fixed‐dose combination of orlistat and acarbose (MR‐OA) was compared with conventional orlistat (CO) regarding toler...

Full description

Bibliographic Details
Main Authors: Ulf Holmbäck, Anders Forslund, Stefan Grudén, Göran Alderborn, Arvid Söderhäll, Per M. Hellström, Hans Lennernäs
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Obesity Science & Practice
Subjects:
gastrointestinal tolerability
modified release
obesity
type‐2 diabetes
Online Access:https://doi.org/10.1002/osp4.405

Similar Items

Similar Items